Implications and emerging control strategies for ventilator-associated infections

Area of Science:

• Medical Microbiology
• Biomaterials Science
• Infectious Diseases

Background:

• Ventilator-associated pneumonia (VAP) poses a substantial threat to intensive care unit patients requiring mechanical ventilation.
• VAP accounts for over 50% of antibiotic prescriptions in ventilated patients.
• Biofilm formation by pathogens like Pseudomonas aeruginosa and Staphylococcus aureus on endotracheal tubes contributes significantly to VAP pathogenesis.

Purpose of the Study:

• To review current strategies for preventing biofilm colonization on endotracheal tubes.
• To discuss methods that inhibit bacterial biofilm formation on medical devices.
• To highlight approaches for reducing VAP incidence.

Main Methods:

• Literature review of existing research on VAP and endotracheal tube biofilms.
• Analysis of strategies including antibiotic treatments.
• Evaluation of surface modification techniques for endotracheal tubes.
• Assessment of antimicrobial agent incorporation into biomaterials.

Main Results:

• Biofilms on endotracheal tubes provide a protective niche for bacteria, increasing antibiotic resistance.
• Current strategies aim to disrupt biofilm formation or eradicate existing biofilms.
• Various approaches are being investigated to enhance endotracheal tube resistance to microbial colonization.

Conclusions:

• Preventing biofilm formation on endotracheal tubes is crucial for combating VAP.
• A combination of strategies, including advanced material science and targeted antimicrobial approaches, may offer the most effective solution.
• Further research into novel anti-biofilm strategies is warranted to reduce the burden of VAP.